 |
 |
|
|
|
|
(...composed on USAir en route to Phoenix from Burbank...) Yesterday was amazing, in fact it feels like part of today, because I woke up in Vista, spent the day working (productively, yay), had a fantastic dinner with colleagues and friends in Carlsbad (at which, I'll note we sampled a mini-vertical of Duckhorn Three Palms merlots, and concluded once more they are amazing), drove home, slept for three hours, got up and drove to Burbank airport, and here I am... whether this bodes well for my meetings later today remains to be seen :) Scott "Dilbert" Adams is calling the bottom: "In January I wrote a post about Captain Sullenberger safely landing his plane in the Hudson River. At the end of the post I said it was a sign that the economy had reached bottom and would soon improve, thanks largely to what I predicted would be an upsurge in consumer confidence...". And this appears to be exactly what happened. But as Scott cautions, "Disclaimer: Don't get your financial, legal, or medical advice from cartoonists."
From the department of unintended consequences: "Bond investors literally can't afford to lend to unionized companies because it's clear that current power in Washington will take the unions' side, despite past bankruptcy law precedents that favor senior creditors. That means Washington's actions in pushing for these bankruptcy verdicts to come out in favor of the unions will probably hurt unionized companies in the long run." Repeat after me: governments should not be involved in markets... President Obama's response to North Korea's apparently successful test of a nuclear weapon: "'Let's be clear: we are not taking adverbs off the table,' Mr. Obama said. 'If the need arises, we will use them forcefully, aggressively, swiftly, overwhelmingly and commandingly'." As Powerline notes, no verbs in prospect.
FierceBiotech reports Cougar trial sees big response to prostate cancer drug. "Researchers say that Cougar's lead drug candidate--abiraterone acetate--produced positive data in a small clinical study on prostate tumors. Abiraterone is designed to stop the body from producing a hormone tumor cells thrive on. Imaging scans of the 54 patients in the study demonstrated that nine of 24 subjects demonstrated a decrease in tumor size." Excellent! Cult of Mac reports iPhone under fire: "For the first time since the announcement of the original iPhone, there are legitimate competitors all around, many of them even approaching Apple’s thinking in creating a holistic ecosystem of supporting software, third-party development and services. There are three big threats to the rise of the iPhone right now: Palm Pre, mass availability of Android, and the Zune HD platform". The iPhone will do just fine, competition is good.
|
|
